AbCellera Biologics

ABCLNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.097 B

$12.65 -0.08%

Close of 22 Sept 2026

Revenue

$75.1M

#2601 by revenue

Earnings

-$146.4M

Loss-making

Shares outstanding

306,611,466

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#64Indivior PharmaceuticalsINDV$4.27B
#65Amylyx PharmaceuticalsAMLX$4.14B
#66AbCellera BiologicsABCL$4.10B
#67Telix PharmaceuticalsTLX$4.05B
#68IDEAYA BiosciencesIDYA$3.83B

Insiders buying

All insider buying →

3 open-market purchases by officers and directors of AbCellera Biologics, worth $975.2K. Grants and option exercises are excluded.

John S. Montalbano$110.3K
10,000 shares at $11.03 on 18 Aug 2026 · filed 18 Aug 2026
Michael R. Hayden$481.0K
46,387 shares at $10.37 on 12 Aug 2026 · filed 14 Aug 2026
Andrew BoothChief Financial Officer$383.9K
37,200 shares at $10.32 on 14 Aug 2026 · filed 14 Aug 2026

What if AbCellera Biologics were worth as much as…

Open the what-if tool →

Gold $30.2T

$93,341.94

Per share 7,379× higher

Bitcoin $1.74T

$5,377.05

Per share 425× higher

Nvidia $5.52T

$17,028.94

Per share 1,346× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for AbCellera Biologics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.